# An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant Depression

> **NCT00070694** · PHASE2 · COMPLETED · sponsor: **National Institute of Mental Health (NIMH)** · enrollment: 96 (—)

## Conditions studied

- Depressive Disorder

## Interventions

- **DRUG:** MDL100.907

## Key facts

- **NCT ID:** NCT00070694
- **Lead sponsor:** National Institute of Mental Health (NIMH)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** —
- **Final completion:** 2004-10
- **Target enrollment:** 96 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00070694

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00070694, "An Investigation of the Antidepressant Efficacy of the 5-HT2A Antagonist, M100907, in Combination With Citalopram in Treatment Resistant Depression". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00070694. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*